Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019

被引:1
|
作者
Wu, Ying [1 ]
Deng, Yujiao [2 ]
Dai, Zhijun [3 ,4 ]
Ma, Yubo [1 ]
Lyu, Lijuan [4 ]
Lei, Chen [5 ]
Zheng, Yi [2 ]
Li, Yizhen [4 ]
Wang, Ziming [1 ,7 ]
Gao, Jie [2 ,6 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Breast Surg, Hangzhou, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China
[5] Ningxia Med Univ, Dept Endocrinol, Gen Hosp, Yinchuan, Peoples R China
[6] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian 710004, Peoples R China
[7] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian 710004, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 15期
关键词
bladder cancer; DALY; death; high fasting plasma glucose; DIABETES-MELLITUS; CIGARETTE-SMOKING; RISK; PREVALENCE; COUNTRIES; CONSUMPTION; MIDDLE;
D O I
10.1002/cam4.6219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. Methods: Bladder cancer data attributable to high FPG were extracted from the Global Burden of Disease Study 2019, and analyzed by age, sex, year, and location. Age-standardized rates were utilized to evaluate the burden between different populations. The temporal trend of the burden was estimated through the Joinpoint analysis. Results: In 2019, high FPG contributed to 22,823.33 (95% uncertainty interval [UI], 4694.88-48,962.26) deaths and 399,654.91 (95% UI, 81,609.35-865,890.95) disability-adjusted life years (DALYs) of bladder cancer globally. Since 1990, the global age-standardized death and DALY rates of bladder cancer attributable to high FPG increased apparently by 39.18% and 41.48%, respectively. During the last 30 years, high FPG-related age-standardized death and DALY rates of bladder cancer have increased in all countries. In 2019, Central Europe showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer, but Andean Latin America had the lowest rates. Nationally, Lebanon showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer in 2019. High FPG-attributable deaths and DALYs of bladder cancer were more considerable among males and older people. Countries with high SDI showed higher levels of age-standardized death and DALY rates of bladder cancer due to high FPG and presented remarkable upward trends in rates in the last 30 years. Conclusions: Globally, the high FPG-associated bladder cancer burden has remarkably increased in all countries, and showed a higher level among countries with higher SDI. Monitoring FPG levels among patients with bladder cancer is critical to lower the corresponding burden.
引用
下载
收藏
页码:16469 / 16481
页数:13
相关论文
共 50 条
  • [1] The burden of cardiovascular disease attributable to high fasting plasma glucose:Findings from the global burden of disease study 2019
    Dong, Xin-Jiang
    Zhang, Xiao-Qi
    Wang, Bei-Bei
    Hou, Fei-Fei
    Jiao, Yang
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (05)
  • [2] Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
    Wang, Minmin
    Liu, Jingyi
    Yan, Liang
    Wang, Jia
    Jin, Yinzi
    Zheng, Zhi-Jie
    JOURNAL OF NUTRITION HEALTH & AGING, 2024, 28 (06):
  • [3] Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
    Ziyi Li
    Na Yang
    Liyun He
    Jialu Wang
    Fan Ping
    Wei Li
    Lingling Xu
    Huabing Zhang
    Yuxiu Li
    Diabetology & Metabolic Syndrome, 15
  • [4] Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study
    Li, Ziyi
    Yang, Na
    He, Liyun
    Wang, Jialu
    Ping, Fan
    Li, Wei
    Xu, Lingling
    Zhang, Huabing
    Li, Yuxiu
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [5] The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019
    Liang, Ruyi
    Feng, Xiaobing
    Shi, Da
    Yang, Meng
    Yu, Linling
    Liu, Wei
    Zhou, Min
    Wang, Xing
    Qiu, Weihong
    Fan, Lieyang
    Wang, Bin
    Chen, Weihong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (08)
  • [6] Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study
    Liu, Yang
    Wang, Wenxin
    Huang, Xuewei
    Zhang, Xingyuan
    Lin, Lijin
    Qin, Juan-Juan
    Lei, Fang
    Cai, Jingjing
    Cheng, Bo
    JOURNAL OF DIABETES, 2022, 14 (08) : 495 - 513
  • [7] Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019
    Wei, Huizhi
    Ren, Jinhong
    Li, Rui
    Qi, Xiaoming
    Yang, Fan
    Li, Qingshan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [8] Global burden of noncommunicable diseases attributable to high fasting plasma glucose
    Ye, Lingxia
    Xu, Jingya
    Zhang, Tianyue
    Lin, Xiling
    Pan, Xiaowen
    Zeng, Wenheng
    Ren, Yuezhong
    Shan, Pengfei
    JOURNAL OF DIABETES, 2020, 12 (11) : 807 - 818
  • [9] Global, Regional, National Burden of Lung Cancer Attributable to High Fasting Plasma Glucose
    Wang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S739 - S740
  • [10] Temporal trends of ischemic stroke attributable to high fasting plasma glucose in China from the global burden of disease study 2019
    Tang, Liangchen
    Xie, Li
    Liu, Yixin
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15